國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Endocannabinoids

Pertwee, Roger G.

Endocannabinoids

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Endocannabinoidsedited by Roger G. Pertwee.
其他作者:	Pertwee, Roger G.
出版者:	Cham :Springer International Publishing :2015.
面頁冊數:	xii, 475 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	CannabinoidsPhysiological effect.
電子資源:	http://dx.doi.org/10.1007/978-3-319-20825-1
ISBN:	9783319208251$q(electronic bk.)

Endocannabinoids
Endocannabinoids[electronic resource] /edited by Roger G. Pertwee. - Cham :Springer International Publishing :2015. - xii, 475 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2310171-2004 ;. - Handbook of experimental pharmacology ;208..

There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment". This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.

ISBN: 9783319208251$q(electronic bk.)

Standard No.: 10.1007/978-3-319-20825-1doiSubjects--Topical Terms:

275140
Cannabinoids
--Physiological effect.

LC Class. No.: QP801.C27

Dewey Class. No.: 615.7827

Endocannabinoids
LDR:01433nmm a2200313 a 4500 001 476346
003 DE-He213
005 20160407132232.0
006 m d
007 cr nn 008maaau
008 160526s2015 gw s 0 eng d
020 $a 9783319208251$q(electronic bk.)
020 $a 9783319208244$q(paper)
024 7 $a 10.1007/978-3-319-20825-1 $2 doi
035 $a 978-3-319-20825-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QP801.C27
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 615.7827 $2 23
090 $a QP801.C27 $b E56 2015
245 0 0 $a Endocannabinoids $h [electronic resource] / $c edited by Roger G. Pertwee.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xii, 475 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.231
520 $a There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment". This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.
650 0 $a Cannabinoids $x Physiological effect. $3 275140
650 0 $a Pharmacology, Experimental. $3 274313
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Cell Biology. $3 274165
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Psychopharmacology. $3 252258
650 2 4 $a Immunology. $3 189152
650 2 4 $a Cytokines and Growth Factors. $3 379480
700 1 $a Pertwee, Roger G. $3 730917
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-20825-1
950 $a Biomedical and Life Sciences (Springer-11642)